Blog
  • Omnichannel
  • Oncology
  • Conferences
  • PERxCEPT
  • Ferma.AI
Kinga Zapert

Kinga Zapert

17 posts •
Oncologists share exclusive insights on the developments in breast cancer therapies in the past year
Oncology

Oncologists share exclusive insights on the developments in breast cancer therapies in the past year

Breast Cancer Awareness Month (BCAM) is a time to celebrate the strength of breast cancer survivors and to champion all of those who are fighting to eradicate this group of diseases. At ZoomRx,

  • Kinga Zapert
    Kinga Zapert
  • Karni Medh
    Karni Medh
  • Manoj Hariharaputhiran
    Manoj Hariharaputhiran
  • Genevieve White
    Genevieve White
5 min read
Cancer Moonshot: Oncologists express optimism about cutting cancer-related deaths
Oncology

Cancer Moonshot: Oncologists express optimism about cutting cancer-related deaths

Oncologists on the ZoomRx panel express their thoughts on the Cancer Moonshot initiative.

  • Karni Medh
    Karni Medh
  • Kinga Zapert
    Kinga Zapert
  • Manoj Hariharaputhiran
    Manoj Hariharaputhiran
4 min read
2022 ASCO Annual Meeting: Major Scientific Progress Moves the Field of Oncology Beyond COVID
Oncology

2022 ASCO Annual Meeting: Major Scientific Progress Moves the Field of Oncology Beyond COVID

A strong line up of potentially practice-changing presentations generated a great deal of excitement among attendees at ASCO#2022 – both those in person at the McCormick Convention Center and those attending virtually. Based

  • Brooke Nelson
  • Kinga Zapert
    Kinga Zapert
  • Abuzaid Ansari
    Abuzaid Ansari
  • Karan Rangra
    Karan Rangra
6 min read
Oncologists' Perspectives on Recent Developments in Advanced Breast Cancer: Promising Progress with Curative Intent Just Out of Reach
Oncology

Oncologists' Perspectives on Recent Developments in Advanced Breast Cancer: Promising Progress with Curative Intent Just Out of Reach

Recent developments across three subtypes of advanced breast cancer – HER2+, TNBC, and HR+/HER2- have generated enthusiasm among oncologists in the United States. While oncologists are stopping short of calling advanced breast cancer

  • Jeff DiDaniels
    Jeff DiDaniels
  • Kinga Zapert
    Kinga Zapert
  • Aadarsh Poduval
    Aadarsh Poduval
  • Neelakanteshwar Reddy Rebala
6 min read
New Data in Early Settings and the Continued Development of Immunotherapies Captured Attention during ASCO's 2021 Annual Meeting.
Conferences

New Data in Early Settings and the Continued Development of Immunotherapies Captured Attention during ASCO's 2021 Annual Meeting.

Among clinical topics, new data in early settings and continued development of immunotherapies stood out to oncologists as areas that can change their practice in the immediate future.

  • Kinga Zapert
    Kinga Zapert
  • Abuzaid Ansari
    Abuzaid Ansari
  • Manas Raheja
    Manas Raheja
  • M Bala Harihar
    M Bala Harihar
  • David Santucci
    David Santucci
6 min read
ESMO 2020 delivered data representing major progress in oncology, as oncologists grow more accustomed to the virtual format

ESMO 2020 delivered data representing major progress in oncology, as oncologists grow more accustomed to the virtual format

Oncologists are growing accustomed to attending the field’s major meetings virtually, with AACR, ASCO, and now ESMO 2020 having gone fully digital.While the virtual format has undoubtedly impacted attendees’ experiences and

  • Kinga Zapert
    Kinga Zapert
  • Aravind Nagarajan
    Aravind Nagarajan
  • Nithya Jyothi
    Nithya Jyothi
  • Varun Venkatesan
    Varun Venkatesan
5 min read
Understanding the role of PSA In Prostate Cancer Oncologist-Patient Dialogue

Understanding the role of PSA In Prostate Cancer Oncologist-Patient Dialogue

The prostate-specific antigen (PSA) score has become a critical post-diagnosis tool for oncologists as they discuss prostate cancer disease state with their patients along with their families and caregivers.Oncologist-patient relationships are based

  • Vinny Valant
    Vinny Valant
  • Kinga Zapert
    Kinga Zapert
3 min read
ASCO20 Delivered Practice-Changing Data in a Highly Accessible, Virtual Format; Despite Reduced Levels of Engagement among Oncologists

ASCO20 Delivered Practice-Changing Data in a Highly Accessible, Virtual Format; Despite Reduced Levels of Engagement among Oncologists

Despite the disruption and transition to a completely virtual format, 2020 was not an off-year for ASCO. Nearly all oncologists who attended this year’s ASCO Annual Meeting felt that it represented at

  • Kinga Zapert
    Kinga Zapert
  • Melissa Green
    Melissa Green
  • Nathan DeCarolis
    Nathan DeCarolis
  • Vidhya Hariharan
    Vidhya Hariharan
  • Chloe Moss
    Chloe Moss
  • Carter Broad
    Carter Broad
  • Akshay Krishnan
5 min read
ASCO20 Moves From McCormick Place: Oncologists Prepare for a Virtual Meeting

ASCO20 Moves From McCormick Place: Oncologists Prepare for a Virtual Meeting

With the ASCO 2020 Annual Meeting just days away, oncologists are nearly universally planning to “attend” this year’s virtual meeting. However, their participation in the meeting will be less in real-time and

  • Kinga Zapert
    Kinga Zapert
  • Melissa Green
    Melissa Green
  • Vidhya Hariharan
    Vidhya Hariharan
  • Nathan DeCarolis
    Nathan DeCarolis
4 min read
Telemedicine and Breast Cancer Patient Care during the COVID-19 Pandemic: Oncologists' Perspective

Telemedicine and Breast Cancer Patient Care during the COVID-19 Pandemic: Oncologists' Perspective

COVID-19 has served as a catalyst for the rapid uptake of telemedicine across a range of therapeutic categories. Initially, physicians adopted telemedicine, despite uncertainty surrounding reimbursement, in order to ensure the safety of

  • Kinga Zapert
    Kinga Zapert
  • Anu Mohan
    Anu Mohan
  • Sangeetha Govindarajan
    Sangeetha Govindarajan
  • Natielle Lohman
    Natielle Lohman
3 min read
ASH 2019: Hem-oncs share their perspective on the latest in MM and CLL treatment among other key topics

ASH 2019: Hem-oncs share their perspective on the latest in MM and CLL treatment among other key topics

Nearly 30,000 hematology specialists gathered for this year’s 2019 American Society of Hematology (ASH) annual meeting held Dec 7-10 in Orlando, Florida. This year’s conference delivered on its promise to

  • Kinga Zapert
    Kinga Zapert
  • Anu Mohan
    Anu Mohan
  • Laurence Meloty-Kapella
    Laurence Meloty-Kapella
4 min read
Getting ready for ASH 2019: Perspective from the ZoomRx hem-onc panel

Getting ready for ASH 2019: Perspective from the ZoomRx hem-onc panel

The ASH 2019 Annual Meeting kicks-off this Saturday (12/7) in Orlando. Our survey of 51 practicing hematologists-oncologists indicated a great deal of excitement and anticipation, as they prepare for the meeting.In

  • Kinga Zapert
    Kinga Zapert
  • Anu Mohan
    Anu Mohan
  • Laurence Meloty-Kapella
    Laurence Meloty-Kapella
3 min read
JAKs continue to capture attention, new MOAs stir excitement at ACR 2019

JAKs continue to capture attention, new MOAs stir excitement at ACR 2019

This year’s annual meeting held November 8-13 did not disappoint according to a ZoomRx survey with 35 rheumatologists who attended the conference.

  • Kinga Zapert
    Kinga Zapert
  • Laurence Meloty-Kapella
    Laurence Meloty-Kapella
3 min read
Oncologists on ESMO 2019 and the Potential Impact of Key PARP Inhibitor Data

Oncologists on ESMO 2019 and the Potential Impact of Key PARP Inhibitor Data

Following this year’s ESMO annual meeting we asked a group of oncologists practicing in the US to weigh in on Europe’s biggest oncology conference. Oncologists expressed general excitement about the meeting,

  • Aravind Nagarajan
    Aravind Nagarajan
  • Kinga Zapert
    Kinga Zapert
3 min read
Oncologists reflect on ASCO 2019

Oncologists reflect on ASCO 2019

The data shared at this year's ASCO Annual Meeting moved the field of clinical oncology forward.Our survey with over 60 oncologists who attended the conference shows that ASCO 2019 did not disappoint.

  • Kinga Zapert
    Kinga Zapert
  • Olivia Green
    Olivia Green
3 min read
Practicing Oncologists Weigh In on ASCO's 2019 Annual Meeting

Practicing Oncologists Weigh In on ASCO's 2019 Annual Meeting

With ASCO just days away, oncologists are divided in their outlook for this year's meeting. In our survey of 54 practicing oncologists who plan on attending the conference, half (52%) reported they expect

  • Kinga Zapert
    Kinga Zapert
  • Olivia Green
    Olivia Green
3 min read
Breakthrough Treatments and Pharma's Pricing Dilemma - Perspective from AAN 2019

Breakthrough Treatments and Pharma's Pricing Dilemma - Perspective from AAN 2019

The recent 2019 AAN conference (May 4-10, Philadelphia) brought promising new data in rare diseases, generating a great deal of excitement and anticipation for new therapies.

  • Kinga Zapert
    Kinga Zapert
  • Brittany Gazdag
    Brittany Gazdag
3 min read

All rights reserved ZoomRx - 2020.   Privacy Policy


HOME
PERSPECTIVES
PANELISTS
CAREERS